All News

Andrew Maiorini, PharmD, FAHM, vice president of clinical programs at PerformRx, discusses the ongoing issue of medication nonadherence and the pharmacists’ crucial role in managing it.

Researchers aim to understand patients’ perception of whether or not they have sufficient information on contraceptives.

Explore effective strategies for managing menstrual pain, including diet, exercise, and nonpharmacological therapies, while embracing women's health awareness.

Joanna Lewis, PharmD, MBA explores effective over-the-counter solutions for menstrual cramps, including NSAIDs, supplements, and tips for optimal relief.

Abortion clinic closures impact reproductive health access, prompting a shift toward pharmacists for contraceptive care and highlighting urgent public health needs.

The panel discussion features pharmacy leaders, policy experts, and well-known legal minds discussing the Most Favored Nation drug policy and its overarching implications.

While the new guidelines are reserved for critical care pharmacists in the ICU, they can be applied to other practice areas, highlighting the crucial role pharmacists play in health care.

Due to an increased risk of vaccine-preventable diseases, researchers explore pneumococcal, COVID-19, and influenza vaccine coverage among people living with HIV in Belgium.

As part of the guidance, the FDA emphasizes drug development, specifically with trial design, patient populations, and outcomes such as reducing the need for opioids.

Researchers conduct a proof-of-concept study exploring the feasibility of health information technology interoperability between a medical office and independent pharmacies.

Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, led a 21-member panel on critical care pharmacists and joined us to discuss how guideline updates may impact the greater pharmacy industry.

In hospitalized patients with obesity, researchers conduct a study detailing how electronic clinical support helps participants optimize their treatment regimens.

Along with additional bills to further bolster PBM reform, the organizations are aiming to pass the PBM Reform Act for improved medication costs and community pharmacy sustainability.

Andrea Sikora, PharmD, MSCR, FCCM, FCCP, BCCCP, chair of the committee presenting new guidelines, discussed her role in bolstering pharmacists’ support in the ICU.

Among individuals with both diabetes and HIV, researchers determine patients’ adherence to comprehensive diabetes care interventions.

The Medicare Drug Price Negotiation Program is anticipated to cause multiple issues for pharmacy owners and their cashflow sustainability.

Olezarsen significantly reduces triglycerides and acute pancreatitis events, offering new hope for patients with severe hypertriglyceridemia.

Medtronic’s diabetes management technology reached 2 milestones upon FDA approval, allowing integration of continuous glucose monitoring for patients with type 1 and type 2 diabetes.

After experiencing tragedy in his personal life, Bil Schmidtknecht was led to join the community of independent pharmacists and industry advocates calling for PBM reform across both aisles.

Exploring the influences of pneumococcal disease mortality and events of the COVID-19 pandemic, researchers investigate changes in US pneumococcus survival rates since 2020.

In pharmacies in predominantly Black and Latino neighborhoods, only 18% and 17% were likely to carry buprenorphine compared with White neighborhoods.

Orforglipron shows results in weight loss and diabetes management, offering a new oral treatment option for patients.

With hypertension commonly leading to increased risk of mortality, researchers aimed to understand the hypertensive survival rates of patients with diabetes over a 20-year period.

Regardless of which stakeholders are involved, a collective, team effort is necessary to achieve state- and federal-level PBM reform.

CVS will not offer COVID-19 vaccines in Massachusetts, Nevada, and New Mexico.

A real-world study found that semaglutide significantly reduced the risk of major cardiovascular events compared to tirzepatide.

Using results from the Rx for Change program in Pittsburgh, Pennsylvania, researchers explored an integrative approach to cardiometabolic disease management among Black patients.

The FDA approves denosumab-nxxp (Bildyos and Bilprevda), enhancing access to vital bone health treatments for osteoporosis and cancer-related conditions.